Metis Global Partners’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1M Sell
226,949
-5,737
-2% -$409K 0.42% 33
2025
Q4
$14.4M Buy
232,686
+12,038
+5% +$708K 0.34% 45
2025
Q3
$13M Buy
220,648
+60,491
+38% +$3.53M 0.31% 47
2025
Q2
$9.33M Buy
160,157
+15,176
+10% +$858K 0.24% 66
2025
Q1
$7.2M Buy
144,981
+1,424
+1% +$72.9K 0.2% 89
2024
Q4
$6.42M Buy
143,557
+19,240
+15% +$913K 0.19% 81
2024
Q3
$5.97M Buy
124,317
+42,167
+51% +$2.03M 0.19% 93
2024
Q2
$4.18M Buy
82,150
+9,504
+13% +$520K 0.14% 119
2024
Q1
$3.95M Buy
72,646
+1,244
+2% +$64.8K 0.14% 125
2023
Q4
$4.02M Buy
71,402
+6,982
+11% +$395K 0.16% 118
2023
Q3
$3.98M Buy
64,420
+2,921
+5% +$185K 0.19% 109
2023
Q2
$3.63M Buy
61,499
+37,123
+152% +$2.36M 0.2% 102
2023
Q1
$1.8M Buy
24,376
+2,315
+10% +$179K 0.12% 185
2022
Q4
$1.61M Buy
22,061
+4,401
+25% +$348K 0.14% 164
2022
Q3
$1.47M Sell
17,660
-2,659
-13% -$229K 0.24% 97
2022
Q2
$1.62M Buy
20,319
+528
+3% +$51.3K 0.26% 88
2022
Q1
$2.05M Buy
+19,791
New +$1.64M 0.25% 77

Other funds holding NTR

Metis Global Partners's NTR Position: Q1 2026 in Review

Metis Global Partners reduced its Nutrien (NTR) stake by 2.5% in Q1 2026, selling an estimated $409K and leaving 226,949 shares worth $17.1M. The position accounts for 0.42% of the portfolio, ranked #33.

Metis Global Partners first reported a position in NTR in Q1 2022 and has held it in 17 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Metis Global Partners held 226,949 shares of Nutrien worth $17.1M as of Q1 2026.
  • Metis Global Partners sold 5,737 Nutrien shares in Q1 2026, an estimated $409K.
  • Nutrien made up 0.42% of Metis Global Partners's portfolio in Q1 2026, its #33 holding.
  • Metis Global Partners first reported a position in Nutrien in Q1 2022 and has held it in 17 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.